Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Flex Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – FLKS

NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Flex Pharma, Inc. (“Flex Pharma” or the “Company”) (NASDAQ:FLKS) and certain of its officers.   The class action, filed in United States …
Go to Source